Summary of clinical results
DUCRAY
Consumer use test of MELASCREEN Protective anti-spots cream
Consumer use test of MELASCREEN Protective anti-spots cream SPF50+ in subjects with superficial facial hyperpigmentation
Population
- 100 adult women (18 to 65 years old) with superficial facial hyperpigmentation and users of a non-tinted SPF50+ photoprotector for dry skin
- Study conducted in Mexico
Application of MELASCREEN Anti-spots cream SPF50+
At home application, depending on to the consumer's care habits for 3 weeks
Evaluation criteria
Cosmetic acceptability and perceived efficacy questionnaire
Résultats
- EPerceived efficacy (percent satisfaction):
- Protective effect of the skin against external damage perceived by 100% of the subjects after 3 weeks
- Reduction of existing hyperpigmentation perceived by 87% of subjects after 3 weeks
- Excellent cosmetic acceptability after 3 weeks of use:
Conclusion
- Protective efficacy and improvement of hyperpigmentation perceived from 1 month
- Excellent cosmetic acceptability
More summaries of clinical results
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.